Frederiksstaden Pharma ApS
CVR 25630483 · Private limited company (ApS) · Active · Medium risk
Frederiksstaden Pharma ApS is a Private limited company (ApS), founded on , based in København K. The company is registered in the industry pakkeriaktiviteter. Our model estimates a bankruptcy risk of 2.0% over the next 12 months, which is 1.4 times the average for Danish companies. 20 annual reports have been published, of which 1 more than six months after the end of the financial year. The latest annual report (31 Dec 2025) shows equity of DKK 238k and a net result of DKK 140k. CEO: Jens-Nikolaj Schøier.
Bankruptcy risk for Frederiksstaden Pharma ApS
1.4 × the average (1.41%) · higher risk than 82% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 25630483
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (26 years)
- Address
- Frederiksgade 11, st. th
1265 København K - Municipality
- København
- Industry
- Pakkeriaktiviteter (829200)
Bankruptcies in the industry: Kombinerede administrationsserviceydelser - Share capital
- DKK 159k
- Employees
- 7 (2018)
- Auditor
- KPMG P/S
- Audit opted out
- No
Warning signs
| Annual reports filed late | 2 of 23 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 27.5% |
| Current ratio | 31% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 11 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 53 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Gross profit | DKK 62k | DKK -39k | DKK -80k |
| Net profit | DKK 140k | DKK -51k | DKK -82k |
| Equity | DKK 238k | DKK 98k | DKK 149k |
| Total assets | DKK 864k | DKK 407k | DKK 328k |
| Short-term debt | DKK 626k | DKK 309k | – |
| Avg. employees | 0 | – | – |
Latest annual report: Reporting class B · auditor's statement: Den uafhængige revisors erklæring · KPMGStatsautoriseret Revisionspartnerselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 177 | ||
| 1 Jan 2024 – 31 Dec 2024 | 87 | ||
| 1 Jan 2023 – 31 Dec 2023 | 169 | ||
| 1 Jan 2022 – 31 Dec 2022 | 174 | ||
| 1 Jan 2021 – 31 Dec 2021 | 111 | ||
| 1 Jan 2020 – 31 Dec 2020 | 90 | ||
| 1 May 2018 – 30 Apr 2019 | 56 | ||
| 1 May 2017 – 30 Apr 2018 | 157 | ||
| 1 May 2016 – 30 Apr 2017 | 149 | ||
| 1 Jan 2014 – 31 Dec 2014 | 170 | ||
| 1 Jan 2013 – 31 Dec 2013 | 146 | ||
| 1 Jan 2012 – 31 Dec 2012 | 150 | ||
| 1 Jan 2011 – 31 Dec 2011 | 159 | ||
| 1 Jan 2010 – 31 Dec 2010 | 158 | ||
| 1 Jan 2009 – 31 Dec 2009 | 154 | ||
| 1 Jan 2008 – 31 Dec 2008 | 159 | ||
| 1 Jan 2007 – 31 Dec 2007 | 142 | ||
| 1 Jan 2006 – 31 Dec 2006 | 175 | ||
| 1 Jan 2005 – 31 Dec 2005 | 465 | Late | |
| 1 Jan 2004 – 31 Dec 2004 | 156 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Jens-Nikolaj Schøier | Current | |
| CEO | Helle Bøwadt | ||
| CEO | Lars Karlsmose | ||
| CEO | Jens-Nikolaj Schøier | ||
| CEO | Klaus Snej Jensen | ||
| CEO | Susanne Ølsgaard Felumb | ||
| CEO | Rolf Eckersberg | ||
| Board | Lars Grundtvig | ||
| Board | Hans Flemming Haagen Jensen | ||
| Board | Helle Bøwadt | ||
| Board | Hans Flemming Haagen Jensen | ||
| Board | Helle Bøwadt | ||
| Board | Lars Grundtvig | ||
| Board | Lars Karlsmose | ||
| Board | Henrik Grundtvig | ||
| Board | Michael Grundtvig | ||
| Board | Henrik Grundtvig | ||
| Board | Lars Karlsmose | ||
| Board | Mohammad Sohail Asghar | ||
| Board | Per Ludvigsen | ||
| Board | Jens-Nikolaj Schøier | ||
| Board | Jens-Nikolaj Schøier | ||
| Board | Søren Wang Petersen | ||
| Board | Susanne Ølsgaard Felumb | ||
| Board | Rolf Eckersberg | ||
| Owner (100%) | XGX Pharma ApS | Current | |
| Owner (67%) | HB-MEDICAL HOLDING ApS | ||
| Owner (10%) | Kjær Henningsen Holding ApS | ||
| Owner (100%) | HB MEDICAL SCANDINAVIA A/S | ||
| Owner (100%) | XGX Pharma ApS | ||
| Owner (33%) | CAND.PHARM. POVL M. ASSENS FOND | ||
| Owner (50%) | XGX Pharma ApS | ||
| Owner (10%) | Felumb Holding ApS | ||
| Auditor | KPMG P/S | Current | |
| Auditor | DELOITTE STATSAUTORISERET REVISIONSAKTIESELSKAB | ||
| Auditor | DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB | ||
| Auditor | 18. juni 2024 P/S | ||
| Auditor | PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB | ||
| Auditor | Kreston CM Statsautoriseret Revisions interessentskab | ||
| Founder | HB-MEDICAL HOLDING ApS | Current |
The CEOs' other companies
Jens-Nikolaj Schøier – 8 other companies
- AGENTURET-KBH. ApS Opløst
- HB MEDICAL SCANDINAVIA A/S Fusioneret
- NS EJENDOMME ApS Opløst
- NS HOLDING ApS Opløst
- Razor Partners ApS Opløst
- S-JN INVEST ApS Opløst
- Schøier Holding ApS Active
- XGX Pharma ApS Active
Helle Bøwadt – 5 other companies, of which 1 bankrupt
- Aktieselskabet af 14. februar 2020 Bankrupt 21 Feb 2020
- ALSENSA ApS Compulsorily dissolved
- HB MEDICAL SCANDINAVIA A/S Fusioneret
- HB-MEDICAL HOLDING ApS Active
- Salient Pharma ApS Active
Lars Karlsmose – 48 other companies, of which 1 bankrupt
- Aktieselskabet af 14. februar 2020 Bankrupt 21 Feb 2020
- ACCURATECH ApS Active
- ALVIBRA A/S Active
- ANKER ANDERSEN A/S Active
- ANKER ANDERSEN HOLDING A/S Fusioneret
- AROS ENTREPRISE ApS Active
- AROS MALER ENTREPRISE A/S Active
- AS Solvarmeservice ApS Active
- Aros Clean ApS Active
- Aros Development A/S Active
- Aros Innovate ApS Active
- BENT NYGÅRD ELEKTRONIK ApS Active
- BoxCo 2 ApS Active
- BoxCo 3 ApS Active
- BoxCo ApS Active
- Cabotech A/S Active
- DANPRES A/S Active
- EMMANA HOLDING ApS Active
- Ejendomsselskabet Skødstrup ApS Active
- Elverdalen ApS Active
- GIAS Ejendomme København ApS Active
- GIAS Holding ApS Active
- GIAS Leasing ApS Active
- GRUNDTVIG INVEST A/S Active
- Gias Ejendomme Avedøre Aps Active
- H. JESPERSEN/P.L. Service ApS Active
- HB MEDICAL SCANDINAVIA A/S Fusioneret
- Imbox Protection A/S Active
- JCNS Holding ApS Active
- JMDK ApS Active
Klaus Snej Jensen – 3 other companies, of which 2 bankrupt
- Medican A/S Bankrupt 15 Aug 2023
- XENDO PHARMA SERVICES A/S Bankrupt 23 Mar 2010
- Kannaabis ApS Opløst
Rolf Eckersberg – 21 other companies, of which 1 bankrupt
- DANSK LÆGEMIDDELFORSYNING A/S Bankrupt 24 Apr 2007
- ACTAVIS A/S Fusioneret
- ACTAVIS NORDIC A/S Fusioneret
- ALKALON A/S Active
- ALTERNOVA A/S Fusioneret
- BERTHELSEN HEALTH GROUP ApS Opløst
- DANSK LÆGEMIDDELFORSYNING DLF ApS Fusioneret
- E CONSULT ApS Active
- ECOMED ApS Opløst
- GRENA INVEST ApS Compulsorily dissolved
- GROWTH HOUSE ApS Opløst
- GROWTH HOUSE HOLDING A/S Opløst
- H-PHARMA ApS Opløst
- NORDISK IBU-PHARMA ApS Opløst
- OPHTHA A/S Fusioneret
- ORBITA ApS Fusioneret
- ORIFARM GENERICS HOLDING A/S Active
- SCANPHARM A/S Active
- UNP2 A/S Fusioneret
- VIMINCO A/S Opløst
- XGX Pharma ApS Active
Address history (4 moves)
| Frederiksgade 11, st. th, 1265 København K | |
| c/o C/O Moalem Weitemeyer Advokatpartnersels, Amaliegade 3, 1256 København K | |
| Dr Neergaards Vej 17, 2970 Hørsholm | |
| Kanalholmen 25, 2650 Hvidovre | |
| Rugmarken 26, 3520 Farum |
Former names
| Frederiksstaden Pharma ApS | – now |
| NPPHorsholm ApS | – |
| Nord Pharma Partners ApS | – |
| HB MEDICAL HØRSHOLM APS | – |
| HB-MEDICAL ApS | – |
Employees per year
Other companies at the same address
- AKTIESELSKABET UNIVERSAL REPRO SERVICE Bankrupt
- SFPN INVEST ApS Bankrupt
- A69 ApS Active
- ACORN SPV ApS Active
- AxCap Founders GP ApS Active
- AxCap GP ApS Active
- AxCap Management 1 ApS Active
- BALDERSGADE 48 ApS Active
- BRUNDE STORCENTER ApS Fusioneret
- Bellidavej 20 Holding ApS Active
- Birch SPV ApS Opløst
- CARL BERNHARDSVEJ NR. 9-11 ApS Active
- CD Projects ApS Active
- CEDAR ApS Opløst
- Charlie Tango Management ApS Active
- D14 ApS Active
- DIG Global A/S Active
- DIG Global GP ApS Active
- DIG Investment Management Denmark A/S Active
- Dragon SPV ApS Opløst
- EJENDOMSSELSKABET AF 19.10.1953 ApS Active
- ELM SPV ApS Active
- Ejendomsselskabet Frederiksgade 11 ApS Active
- Entreprenørselskabet af 3/2 2016 ApS Fusioneret
- F7 ApS Active
Similar companies in København
- Basat ApS København S
- Curtec Nordics ApS København Ø
- PETS IVS København K
- DSER ApS København K
Questions and answers about Frederiksstaden Pharma ApS
Has Frederiksstaden Pharma ApS gone bankrupt?
No, Frederiksstaden Pharma ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of Frederiksstaden Pharma ApS?
Our model estimates a bankruptcy risk of 2.0% over the next 12 months (medium risk), which is 1.4 times the average for Danish companies.
Who is the CEO of Frederiksstaden Pharma ApS?
Jens-Nikolaj Schøier is the CEO of Frederiksstaden Pharma ApS.
Who is the auditor of Frederiksstaden Pharma ApS?
Frederiksstaden Pharma ApS most recently used KPMG P/S.
When was Frederiksstaden Pharma ApS founded?
Frederiksstaden Pharma ApS was founded on 20 September 2000.
What is the equity of Frederiksstaden Pharma ApS?
Equity was DKK 238k according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.